Truvada (Emtricitabine / Tenofovir Disoproxil Fumarate) - Published Studies

Truvada Related Published Studies

Well-designed clinical trials related to Truvada (Emtricitabine / Tenofovir Disoproxil)

Bioequivalence of efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen. [2007.10.01]

Pharmacokinetics of emtricitabine, tenofovir, and GS-9137 following coadministration of emtricitabine/tenofovir disoproxil fumarate and ritonavir-boosted GS-9137. [2007.07.01]

Steady-state pharmacokinetics of emtricitabine and tenofovir disoproxil fumarate administered alone and in combination in healthy volunteers. [2007.06]

Other research related to Truvada (Emtricitabine / Tenofovir Disoproxil)

Efavirenz/emtricitabine/tenofovir disoproxil fumarate fixed-dose combination: first-line therapy for all? [2007.02]

Tenofovir disoproxil fumarate-emtricitabine coformulation for once-daily dual NRTI backbone. [2006.08]

Use of tenofovir disoproxil fumarate and emtricitabine combination in HIV-infected patients. [2006.04]

Intravenous lansoprazole: in erosive oesophagitis. [2004]

Other possibly related research studies

Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues. [2006.04.06]

Hepatitis B in liver transplant recipients. [2006.11]

Anti-HIV drugs. [2007]

Short communication: no evidence of occult SHIV infection as demonstrated by CD8+ cell depletion after chemoprophylaxis-induced protection from mucosal infection in rhesus macaques. [2008.04]

Efficacy and safety of once-daily regimens in the treatment of HIV infection. [2008]